132 related articles for article (PubMed ID: 23497964)
21. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study.
Miner P; Katz PO; Chen Y; Sostek M
Am J Gastroenterol; 2003 Dec; 98(12):2616-20. PubMed ID: 14687806
[TBL] [Abstract][Full Text] [Related]
22. Rapid effect of lansoprazole on intragastric pH: a crossover comparison with omeprazole.
Thoring M; Hedenström H; Eriksson LS
Scand J Gastroenterol; 1999 Apr; 34(4):341-5. PubMed ID: 10365892
[TBL] [Abstract][Full Text] [Related]
23. Effects of pumaprazole (BY841), a novel reversible proton pump antagonist, and of omeprazole, on intragastric acidity before and after cure of Helicobacter pylori infection.
Martínek J; Blum AL; Stolte M; Hartmann M; Verdú EF; Lühmann R; Dorta G; Wiesel P
Aliment Pharmacol Ther; 1999 Jan; 13(1):27-34. PubMed ID: 9892876
[TBL] [Abstract][Full Text] [Related]
24. Effects of lansoprazole on human gastric lipase secretion and intragastric lipolysis in healthy human volunteers.
Renou C; Carrière F; Ville E; Grandval P; Joubert-Collin M; Laugier R
Digestion; 2001; 63(4):207-13. PubMed ID: 11435719
[TBL] [Abstract][Full Text] [Related]
25. Time to maximum effect of lansoprazole on gastric pH in normal male volunteers.
Bell NJ; Hunt RH
Aliment Pharmacol Ther; 1996 Dec; 10(6):897-904. PubMed ID: 8971286
[TBL] [Abstract][Full Text] [Related]
26. Initial potency of lansoprazole and omeprazole tablets on pentagastrin-stimulated gastric acid secretion-a placebo-controlled study in healthy volunteers.
Müller P; Göksu MA; Fuchs W; Schlüter F; Simon B
Aliment Pharmacol Ther; 2000 Sep; 14(9):1225-9. PubMed ID: 10971240
[TBL] [Abstract][Full Text] [Related]
27. Early effect of oral administration of omeprazole with mosapride as compared with those of omeprazole alone on the intragastric pH.
Iida H; Inamori M; Fujii T; Sekino Y; Endo H; Hosono K; Nonaka T; Koide T; Takahashi H; Yoneda M; Goto A; Abe Y; Kobayashi N; Kirikoshi H; Kubota K; Saito S; Gotoh E; Maeda S; Nakajima A
BMC Gastroenterol; 2012 Mar; 12():25. PubMed ID: 22448810
[TBL] [Abstract][Full Text] [Related]
28. Influence of lansoprazole on intragastric 24-hour pH, meal-stimulated gastric acid secretion, and concentrations of gastrointestinal hormones and enzymes in serum and gastric juice in healthy volunteers.
Brunner G; Hell M; Hengels KJ; Hennig U; Fuchs W
Digestion; 1995; 56(2):137-44. PubMed ID: 7750667
[TBL] [Abstract][Full Text] [Related]
29. [Effect of a proton pump inhibitor AG-1749 (lansoprazole) on intragastric pH: 24-hour intragastric pH monitoring].
Kihira K; Yoshida Y; Kasano T; Taniguchi Y; Sato K; Kimura K; Hirose M; Koyama H
Nihon Shokakibyo Gakkai Zasshi; 1991 Mar; 88(3):672-80. PubMed ID: 1646341
[TBL] [Abstract][Full Text] [Related]
30. Early effects of oral administration of omeprazole and roxatidine on intragastric pH.
Iida H; Kato S; Sekino Y; Sakai E; Uchiyama T; Endo H; Hosono K; Sakamoto Y; Fujita K; Yoneda M; Koide T; Takahashi H; Tokoro C; Goto A; Abe Y; Kobayashi N; Kubota K; Gotoh E; Maeda S; Nakajima A; Inamori M
J Zhejiang Univ Sci B; 2012 Jan; 13(1):29-34. PubMed ID: 22205617
[TBL] [Abstract][Full Text] [Related]
31. Effects on 24-hour intragastric pH: a comparison of lansoprazole administered nasogastrically in apple juice and pantoprazole administered intravenously.
Freston J; Chiu YL; Pan WJ; Lukasik N; Täubel J
Am J Gastroenterol; 2001 Jul; 96(7):2058-65. PubMed ID: 11467632
[TBL] [Abstract][Full Text] [Related]
32. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
Giral A; Celikel CA; Ozdogan O; Tözün N; Ulusoy NB; Kalayci C
J Gastroenterol Hepatol; 2005 Dec; 20(12):1886-91. PubMed ID: 16336449
[TBL] [Abstract][Full Text] [Related]
33. Studies of various administration methods for lansoprazole injection using 24-hour intragastric pH monitoring.
Inoue M; Nakamura M
J Clin Gastroenterol; 1995; 20 Suppl 2():S17-21. PubMed ID: 7594332
[TBL] [Abstract][Full Text] [Related]
34. Stronger inhibition of gastric acid secretion by lafutidine, a novel H2 receptor antagonist, than by the proton pump inhibitor lansoprazole.
Yamagishi H; Koike T; Ohara S; Horii T; Kikuchi R; Kobayashi S; Abe Y; Iijima K; Imatani A; Suzuki K; Hishinuma T; Goto J; Shimosegawa T
World J Gastroenterol; 2008 Apr; 14(15):2406-10. PubMed ID: 18416470
[TBL] [Abstract][Full Text] [Related]
35. Acid Inhibitory Effect of a Combination of Omeprazole and Sodium Bicarbonate (CDFR0209) Compared With Delayed-Release Omeprazole 40 mg Alone in Healthy Adult Male Subjects.
Kim KN; Yang SW; Kim H; Kwak SS; Kim YS; Cho DY
Clin Pharmacol Drug Dev; 2018 Jan; 7(1):53-58. PubMed ID: 28111929
[TBL] [Abstract][Full Text] [Related]
36. Intragastric acidity during the first day following administration of low-dose proton pump inhibitors: a randomized crossover study.
Hata S; Arai M; Maruoka D; Tanaka T; Matsumura T; Suzuki T; Nakagawa T; Katsuno T; Imazeki F; Yokosuka O
Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):296-301. PubMed ID: 22959094
[TBL] [Abstract][Full Text] [Related]
37. Absence of nocturnal acid breakthrough in Helicobacter pylori-positive subjects treated with twice-daily omeprazole.
Martínek J; Pantoflícková D; Hucl T; Benes M; Dorta G; Lukás M; Spicák J
Eur J Gastroenterol Hepatol; 2004 May; 16(5):445-50. PubMed ID: 15097035
[TBL] [Abstract][Full Text] [Related]
38. Bedtime ranitidine does not eliminate the need for a second daily dose of omeprazole to suppress nocturnal gastric pH.
Khoury RM; Katz PO; Hammod R; Castell DO
Aliment Pharmacol Ther; 1999 May; 13(5):675-8. PubMed ID: 10233192
[TBL] [Abstract][Full Text] [Related]
39. Effect of omeprazole on regional and temporal variations in intragastric acidity.
Viani F; Verdú EF; Idström JP; Cederberg C; Fraser R; Fried M; Blum AL; Armstrong D
Digestion; 2002; 65(1):2-10. PubMed ID: 11961336
[TBL] [Abstract][Full Text] [Related]
40. Preventive effects of lansoprazole and famotidine on gastric mucosal injury induced by low-dose aspirin in Helicobacter pylori-negative healthy volunteers.
Nishino M; Sugimoto M; Kodaira C; Yamade M; Uotani T; Shirai N; Ikuma M; Tanaka T; Sugimura H; Hishida A; Furuta T
J Clin Pharmacol; 2011 Jul; 51(7):1079-86. PubMed ID: 20663999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
